Browsing Tag
Jiangsu Anbison Pharmaceutical
1 post
Ethypharm expands Mesalazine portfolio with strategic acquisition in China
Ethypharm, a global leader in essential medicines for central nervous system disorders, hospital care, and internal medicine, has…